Asthma: Clinical sciences

5,354views

00:00 / 00:00

Assessments

USMLE® Step 2 questions

0 / 4 complete

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

A 42-year-old man is evaluated in the pulmonology clinic for a follow-up visit for asthma that was diagnosed one month ago after spirometry showed an FEV1/FVC ratio of 0.6 and an increase in FEV1 of 15% after albuterol administration. The patient was started on a daily low-dose inhaled corticosteroids (ICS)-long-acting beta-agonists(LABA) inhaler and has noticed an improvement in his symptoms. The patient wakes up short of breath several times weekly and needs to use a short-acting albuterol inhaler several times a day. Physical exam reveals diffuse bilateral wheezing. Serum IgE is 10 IU/mL, and eosinophils are 50 cells/µL. High-resolution CT of the chest is within normal limits. Which of the following is the most appropriate next step in management?  

Transcript

Watch video only

Asthma is an episodic, chronic respiratory disorder characterized by airway obstruction caused by inflammation and hyperresponsiveness of the bronchial smooth muscle. Asthma is reversible, which means the obstruction can virtually disappear with medications like bronchodilators, and inducible, which means the obstruction can occur in response to a variety of stimuli; including allergens, irritants, and respiratory tract infections.

Clinical manifestations are highly variable, ranging from infrequent and mild symptoms that have minimal functional limitations, to frequent acute asthma exacerbations causing significant impairment in functional capacity, and even life-threatening respiratory failure that’s often referred to as status asthmaticus.

Now, if you suspect asthma, you should first perform an ABCDE assessment to determine whether your patient is stable or unstable. If they’re unstable, stabilize their airway, breathing and circulation, obtain IV access, and begin continuous vital sign monitoring including heart rate and blood pressure.

Next, obtain focused history and physical, order labs, including ABG, and perform spirometry to assess the patient’s peak expiratory flow, or PEF, for short. Finally, don’t forget to place your patient on pulse oximetry. History typically reveals shortness of breath, cough, and chest tightness. On the flip side, physical exam is likely to show tachypnea and use of accessory inspiratory muscles. In addition, auscultation can reveal bilateral wheezing due to inflamed and narrowed airways, and if the condition worsens, you may find decreased or even absent breath sounds, since less air is reaching alveoli.

Next ABG might reveal arterial pH of 7.35 or less and pCO2 above 45 mmHg, indicating respiratory acidosis and hypercapnia; while spirometry usually shows PEF less than 40%. Finally, pulse oximetry might demonstrate saturation below 90%.

If this is the case, suspect acute asthma exacerbation, or even status asthmaticus, and immediately administer supplemental oxygen at 100% FiO2, inhaled bronchodilators including a short-acting muscarinic antagonist like ipratropium and a short-acting beta agonist or SABA like albuterol, as well as systemic corticosteroids, either oral or IV. If the patient doesn’t respond to treatment, you can also give a single dose of IV magnesium. Lastly, in severe cases, you may even proceed with endotracheal intubation and mechanical ventilation, especially if your patient has altered mental status, cyanosis, or inability to maintain respiratory effort, as well as worsening hypercapnia and respiratory acidosis.

Now let's go back to the ABCDE assessment and discuss stable patients. First, perform a focused history and physical. Your patient is likely to report shortness of breath, coughing, and chest tightness, often triggered by allergens and exercise, and they may even have an existing diagnosis of asthma. On the other hand, physical examination often reveals tachypnea and wheezing. If this is the case, suspect asthma, or if your patient has already been diagnosed with asthma, suspect worsening of its severity.

You’ll want to monitor the patient's vital signs, including heart rate, blood pressure, respirations, and oxygen saturation. Finally, provide supplemental oxygen to maintain an oxygen saturation above 90%. The next step in patient management is to obtain spirometry, including FVC and FEV1 to confirm the diagnosis. FVC, or forced vital capacity, is the maximum amount of air a person can forcibly exhale from their lungs after a maximum inhalation, while FEV1 is the volume of air exhaled during the first second of this forced exhalation.

Now, here’s a clinical pearl to keep in mind! Spirometry can be performed with a simple handheld spirometer. First, have your patient take a maximal breath in, then forcibly exhale into the spirometer until all of the air is emptied from their lungs. This will generate a flow-volume loop, which will differentiate between obstructive and restrictive patterns of lung disease.

Now that you’ve completed spirometry, calculate the patient’s FEV1 to FVC ratio. If the ratio is within normal range, or even elevated, for the patient’s age, consider an alternative diagnosis. On the other hand, if the ratio is below normal range, suspect an obstructive lung disease, which includes asthma. But this is not enough to confirm the diagnosis so your next step is to perform bronchodilator reversibility, or BDR testing. BDR testing consists of giving an inhaled dose of a SABA, followed by repeat spirometry, paying particular attention to the FEV1.

Sources

  1. "2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group" J Allergy Clin Immunol (2020)
  2. "How to interpret spirometry in a child with suspected asthma" Arch Dis Child Educ Pract Ed (2022)
  3. "A stepwise approach to the interpretation of pulmonary function tests" Am Fam Physician (2014)
  4. "Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes" J Allergy Clin Immunol Pract (2022)